Home/Filings/4/0001567619-21-006025
4//SEC Filing

Campbell James H 4

Accession 0001567619-21-006025

CIK 0000722723other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 5:31 PM ET

Size

10.3 KB

Accession

0001567619-21-006025

Insider Transaction Report

Form 4
Period: 2021-03-08
Campbell James H
SVP, Chief Clinical Officer
Transactions
  • Award

    Common Stock

    2021-03-08+4,65045,926 total
  • Tax Payment

    Common Stock

    2021-03-08$23.99/sh1,425$34,18644,501 total
Holdings
  • Stock Options (right to buy)

    Exercise: $12.77Exp: 2027-05-19Common Stock (27,328 underlying)
    27,328
Footnotes (6)
  • [F1]Represents a grant of time-based restricted stock under the Company's 2019 Omnibus Incentive Plan ("Plan"), which vests to the extent of 25% annually beginning on the first anniversary date of the grant and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 4,650 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2021.
  • [F2]Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued.
  • [F3]Consists of (i) unvested restricted shares totaling 4,650 shares of stock from an initial grant of 4,650 shares of restricted stock that begins to vest on March 8, 2022; (ii) unvested restricted shares totaling 3,873 shares of stock from an initial grant of 3,873 shares of restricted stock that begins to vest on March 9, 2021; (iii) unvested restricted shares totaling 4,556 shares of stock from an initial grant of 4,556 shares of restricted stock that begins to vest on March 9, 2021; (iv) unvested restricted shares and fully vested shares totaling 3,647 shares of stock from an initial grant of 4,405 shares of restricted stock made on March 8, 2019; [continued in next footnote]
  • [F4](v) unvested restricted shares and fully vested shares totaling 4,322 shares of stock from an initial grant of 5,220 shares of restricted stock made on March 8, 2019; (vi) unvested restricted shares and fully vested shares totaling 5,691 shares of stock from an initial grant of 6,710 shares of restricted stock made on March 9, 2018; (vii) unvested restricted shares and fully vested shares totaling 3,623 shares of stock from an initial grant of 7,029 shares of restricted stock made on March 8, 2017; (viii) fully vested shares totaling 1,058 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; and (ix) unvested restricted shares and fully vested shares totaling 2,025 shares of stock from an initial grant of 6,008 shares of restricted stock made on April 29, 2016.
  • [F5]Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
  • [F6]Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.

Documents

1 file

Issuer

HANGER, INC.

CIK 0000722723

Entity typeother

Related Parties

1
  • filerCIK 0001757390

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 5:31 PM ET
Size
10.3 KB